ERAY ERGE

Dr. ERAY ERGE

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2023 in Diseases
Verified
Journal Article
Open access
PDF file
EEERAY ERGE
ERAY ERGE
CKCagri Kiziltunc
Cagri Kiziltunc
Sumeyye Buse BalciSumeyye Buse Balci
Sumeyye Buse Balci
BTBurcin Atak Tel
Burcin Atak Tel
SBSatilmis Bilgin
Satilmis Bilgin
Gulali AktasGulali Aktas
Gulali Aktas
Background: Hashimoto’s thyroiditis (HT) is a chronic autoimmune thyroiditis that causes systemic inflammation in the body, leading to hypothyroidism and an enlargement of the thyroid gland. Objectives: This study aims to reveal whether there is a relationship between Hashimoto’s thyroiditis and the platelet-count-to-lymphocyte-count ratio (PLR), which is used as a new inflammatory marker. Methods: In this retrospective study, we compared the PLR of the euthyroid HT group and the hypothyroid-thyrotoxic HT group to the controls. We also evaluated the values of thyroid-stimulating hormone (TSH), free T4 (fT4), C-reactive protein (CRP), aspartate transaminase (AST), alanine transaminase (ALT), white blood cell count, lymphocyte count, hemoglobin, hematocrit, and platelet count in each group. Results: The PLR of the subjects with Hashimoto’s thyroiditis was found to be significantly different from the control group (p < 0.001), with the rankings as follows: hypothyroid-thyrotoxic HT 177% (72–417) > euthyroid HT 137% (69–272) > control group 103% (44–243). In addition to the increased PLR values, an increase in CRP values was also observed, revealing a strong positive correlation between the PLR and CRP in the HT patients. Conclusion: In this study, we found out that the PLR was higher in the hypothyroid-thyrotoxic HT and euthyroid HT patients than in a healthy control group.

13 June 2023 in Precision Medical Sciences
Verified
Journal Article
Open access
TDTuba Taslamacioglu Duman
Tuba Taslamacioglu Duman
EEERAY ERGE
ERAY ERGE
BTBurcin Atak Tel
Burcin Atak Tel
CKCagri Kiziltunc
Cagri Kiziltunc
Gulali AktasGulali Aktas
Gulali Aktas
Background: The aim of the study was assessing the De Ritis score, an inflammatory marker, in Hashimoto's thyroiditis (HT) patients which is characterized with autoimmunity and chronic inflammation.Methods: Between October 2021 and October 2022, the subjects in our outpatient clinics diagnosed with thyroiditis and healthy controls enrolled to the study. Age, gender, and laboratory parameters including C‐reactive protein (CRP), alanine (ALT), and aspartate (AST) transaminases, thyroid stimulating hormone (TSH), free T4 (FT4), were obtained and recorded for all participants, retrospectively. Division of AST by ALT was the formula to calculate the De Ritis score. Characteristics and laboratory data of the study and healthy controls were compared.Results: Median de Ritis ratio of the HT group (1.11 (0.56)%) was significantly higher than that of the control group (0.91 (0.41)%), (p < .001). A positive and significant correlation between De Ritis score and CRP (r = 0.46, p < .001) values. ROC analysis revealed the sensitivity and the specificity of CRP in predicting HT were higher than those of the De Ritis score. A De Ritis score higher than 0.9% has 67% sensitivity and 50% specificity in selecting patients with thyroiditis (AUC: 0.69, p < .001, 95% CI: 0.63–0.76).Conclusions: We think that elevated De Ritis score can be used as an adjunctive tool in the diagnosis of HT.